← Open Payments lookup

KAILA HARGIS: Open Payments

NPI 1750745964 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$740 in 24 payments from 10 companies in 2025. Trend: 2023 $162 · 2024 $515 · 2025 $740

Food & beverage: $740
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP2$258
Amgen Inc.6$160
Takeda Pharmaceuticals U.S.A., Inc.5$100
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$65
ABBVIE INC.3$47
Neurocrine BioSciences, Inc.1$30
Supernus Pharmaceuticals, Inc.1$29
Almatica Pharma LLC1$22
Vanda Pharmaceuticals Inc.1$17
Noven Therapeutics, LLC1$14

Products named: AIRSUPRA, REPATHA, TRINTELLIX, CAPLYTA, VRAYLAR, KRYSTEXXA, INGREZZA, Qelbree.

Industry payments across LA — which companies pay providers there.